Wakamoto Pharmaceutical Co.,Ltd. 4512.T Stock
Wakamoto Pharmaceutical Co.,Ltd. Price Chart
Wakamoto Pharmaceutical Co.,Ltd. 4512.T Financial and Trading Overview
Wakamoto Pharmaceutical Co.,Ltd. stock price | 237 JPY |
Previous Close | 230 JPY |
Open | 231 JPY |
Bid | 231 JPY x 0 |
Ask | 232 JPY x 0 |
Day's Range | 230 - 233 JPY |
52 Week Range | 212 - 276 JPY |
Volume | 39.1K JPY |
Avg. Volume | 80.37K JPY |
Market Cap | 8.12B JPY |
Beta (5Y Monthly) | 0.508429 |
PE Ratio (TTM) | 59.033077 |
EPS (TTM) | -5.13 JPY |
Forward Dividend & Yield | 6 (2.58%) |
Ex-Dividend Date | March 30, 2023 |
1y Target Est | N/A |
4512.T Valuation Measures
Enterprise Value | 7.79B JPY |
Trailing P/E | 59.033077 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.86112285 |
Price/Book (mrq) | 0.6669848 |
Enterprise Value/Revenue | 0.826 |
Enterprise Value/EBITDA | 15.335 |
Trading Information
Wakamoto Pharmaceutical Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.508429 |
52-Week Change | -7.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 276 JPY |
52 Week Low | 212 JPY |
50-Day Moving Average | 239.86 JPY |
200-Day Moving Average | 232.37 JPY |
4512.T Share Statistics
Avg. Volume (3 month) | 80.37K JPY |
Avg. Daily Volume (10-Days) | 52.73K JPY |
Shares Outstanding | 34.71M |
Float | 24.21M |
Short Ratio | N/A |
% Held by Insiders | 37.58% |
% Held by Institutions | 18.55% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2012 |
Most Recent Quarter (mrq) | March 31, 2012 |
Next Fiscal Year End | March 31, 2013 |
Profitability
Profit Margin | -2.35% |
Operating Margin (ttm) | -5.30% |
Gross Margin | 53.85% |
EBITDA Margin | 5.38% |
Management Effectiveness
Return on Assets (ttm) | -1.83% |
Return on Equity (ttm) | -1.83% |
Income Statement
Revenue (ttm) | 9.43B JPY |
Revenue Per Share (ttm) | 271.03 JPY |
Quarterly Revenue Growth (yoy) | -10.29% |
Gross Profit (ttm) | 5.08B JPY |
EBITDA | 508M JPY |
Net Income Avi to Common (ttm) | -222000000 JPY |
Diluted EPS (ttm) | 3.93 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.87B JPY |
Total Cash Per Share (mrq) | 53.72 JPY |
Total Debt (mrq) | 1.66B JPY |
Total Debt/Equity (mrq) | 13.69 JPY |
Current Ratio (mrq) | 4.296 |
Book Value Per Share (mrq) | 347.834 |
Cash Flow Statement
Operating Cash Flow (ttm) | 589M JPY |
Levered Free Cash Flow (ttm) | -241000000 JPY |
Profile of Wakamoto Pharmaceutical Co.,Ltd.
Country | Japan |
State | N/A |
City | Tokyo |
Address | 2-2-2, Nihonbashi Honcho |
ZIP | 103-8330 |
Phone | 81 3 3297 0371 |
Website | https://www.wakamoto-pharm.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 403 |
Wakamoto Pharmaceutical Co.,Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation; and Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Q&A For Wakamoto Pharmaceutical Co.,Ltd. Stock
What is a current 4512.T stock price?
Wakamoto Pharmaceutical Co.,Ltd. 4512.T stock price today per share is 237 JPY.
How to purchase Wakamoto Pharmaceutical Co.,Ltd. stock?
You can buy 4512.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Wakamoto Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Wakamoto Pharmaceutical Co.,Ltd. is 4512.T.
Which industry does the Wakamoto Pharmaceutical Co.,Ltd. company belong to?
The Wakamoto Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Wakamoto Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Wakamoto Pharmaceutical Co.,Ltd. shares is 34.71M.
What is Wakamoto Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Wakamoto Pharmaceutical Co.,Ltd. PE Ratio is now.
What was Wakamoto Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Wakamoto Pharmaceutical Co.,Ltd. EPS is -5.13 JPY over the trailing 12 months.
Which sector does the Wakamoto Pharmaceutical Co.,Ltd. company belong to?
The Wakamoto Pharmaceutical Co.,Ltd. sector is Healthcare.